Search results

Source:

Scottish Medicines Consortium - SMC (Remove filter)

07 May 2018

Indication: For the long-term treatment of pulmonary arterial hypertension (PAH) in adult patients with WHO functional class (FC) II-III, either as combination therapy in patients insufficiently...

Type:

Guidance (Add filter)

Type:

Prescribing and Technical Information (Add filter)

Source:

Scottish Medicines Consortium - SMC (Remove filter)

09 July 2018

Indication: Treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) after prior chemotherapy. Patients with EGFR activating mutations or ALK-positive tumour...

Type:

Guidance (Add filter)

Type:

Prescribing and Technical Information (Add filter)

Source:

Scottish Medicines Consortium - SMC (Remove filter)

09 July 2018

Indication: Unresectable or metastatic, progressive, well differentiated (G1 and G2) somatostatin receptor positive gastroenteropancreatic neuroendocrine tumours in adults.

Type:

Guidance (Add filter)

Type:

Prescribing and Technical Information (Add filter)

Source:

Scottish Medicines Consortium - SMC (Remove filter)

Indication: Treatment of chronic lymphocytic leukaemia (CLL) in patients who are refractory to fludarabine and alemtuzumab.

Type:

Guidance (Add filter)

Type:

Prescribing and Technical Information (Add filter)

Source:

Scottish Medicines Consortium - SMC (Remove filter)

09 August 2010

Indication: Maintenance treatment of adult patients with schizophrenia sufficiently stabilised during acute treatment with oral olanzapine.

Type:

Guidance (Add filter)

Type:

Prescribing and Technical Information (Add filter)

Source:

Scottish Medicines Consortium - SMC (Remove filter)

10 November 2003

Indication: Hypertension

Type:

Guidance (Add filter)

Type:

Prescribing and Technical Information (Add filter)

Source:

Scottish Medicines Consortium - SMC (Remove filter)

10 December 2012

Indication: In adult patients whose blood pressure is not adequately controlled on the combination of olmesartan medoxomil and amlodipine taken as dual-component formulation.

Type:

Guidance (Add filter)

Type:

Prescribing and Technical Information (Add filter)

Source:

Scottish Medicines Consortium - SMC (Remove filter)

07 November 2016

Indication: Monotherapy for the maintenance treatment of adult patients with platinum-sensitive relapsed BRCA-mutated (germline and/or somatic) high grade serous epithelial ovarian, fallopian tube, ...

Type:

Guidance (Add filter)

Type:

Prescribing and Technical Information (Add filter)

Source:

Scottish Medicines Consortium - SMC (Remove filter)

12 October 2009

Indication: For treatment of essential hypertension

Type:

Guidance (Add filter)

Type:

Prescribing and Technical Information (Add filter)

Source:

Scottish Medicines Consortium - SMC (Remove filter)

12 January 2015

Indication: Maintenance bronchodilator treatment in patients with chronic obstructive pulmonary disease.

Type:

Guidance (Add filter)

Type:

Prescribing and Technical Information (Add filter)